Emory Hilton, DPM
Podiatrist · McAlester, OKNPI 1134184674
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Arthrex at 56.5% of the total. Reporting peaked in 2019 at $744 and has fallen 90.0% since, to $74 in 2025. That places this record below the midpoint for podiatrist clinicians in OK, where the typical reported total is $1,579.
Across 12 payments — averaging $77.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$523
- Pylant Medical$221
- Organogenesis Inc.$55
- Treace Medical Concepts, Inc.$41
- Smith+Nephew$37
- Zimmer Biomet$30
- plus $19 from 1 others
What the payments were for
- Food & beverage$48853%
- Education$43847%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 2 | $523 |
| Pylant Medical | 2 | $221 |
| Organogenesis Inc. | 2 | $55 |
| Treace Medical Concepts, Inc. | 2 | $41 |
| Smith+Nephew | 2 | $37 |
| Zimmer Biomet | 1 | $30 |
| Bioventus LLC | 1 | $19 |
How this compares
$926 in reported general payments places this provider in the 35th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 42 | $1,114 |
| Pregabalin | 33 | $462 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $400 |
| Clindamycin Hcl | 55 | $317 |
| Fluconazole | 16 | $269 |
| Methylprednisolone | 23 | $220 |
| Mupirocin | 18 | $176 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $175 |
| Ciprofloxacin Hcl | 15 | $137 |
| Allopurinol | 23 | $136 |
| Doxycycline Hyclate | 15 | $124 |
| Tramadol Hcl | 28 | $58 |
| Oxycodone Hcl | 12 | $39 |
| Meloxicam | 18 | $15 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in McAlester
- David CavallaroOklahoma City$22K
- Ahmed BukshEdmond$17K
- Aerial AveryAda$13K
- Patricia BoehleOklahoma City$10K
- Kevin DuxMuskogee$8K
- Barinder BassiTahlequah$7K
- Greg RohdeNorman$7K
- Thomas WicksChickasha$6K
- Tera SantistevanSapulpa$5K
- James StoughEnid$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.